Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1453 to 1459 of 1459 entries
Sorted by: Best Match Show Resources per page
What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Frontiers in psychology

Sakuraya A, Imamura K, Watanabe K, Asai Y, Ando E, Eguchi H, Nishida N, Kobayashi Y, Arima H, Iwanaga M, Otsuka Y, Sasaki N, Inoue A, Inoue R, Tsuno K, Hino A, Shimazu A, Tsutsumi A, Kawakami N.
PMID: 33281653
Front Psychol. 2020 Nov 13;11:528656. doi: 10.3389/fpsyg.2020.528656. eCollection 2020.

No abstract available.

Cite
Sakuraya A, Imamura K, Watanabe K, et al. What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Psychol. 2020;11:528656doi: 10.3389/fpsyg.2020.528656.
Sakuraya, A., Imamura, K., Watanabe, K., Asai, Y., Ando, E., Eguchi, H., Nishida, N., Kobayashi, Y., Arima, H., Iwanaga, M., Otsuka, Y., Sasaki, N., Inoue, A., Inoue, R., Tsuno, K., Hino, A., Shimazu, A., Tsutsumi, A., & Kawakami, N. (2020). What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in psychology, 11528656. https://doi.org/10.3389/fpsyg.2020.528656
Sakuraya, Asuka, et al. "What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Frontiers in psychology vol. 11 (2020): 528656. doi: https://doi.org/10.3389/fpsyg.2020.528656
Sakuraya A, Imamura K, Watanabe K, Asai Y, Ando E, Eguchi H, Nishida N, Kobayashi Y, Arima H, Iwanaga M, Otsuka Y, Sasaki N, Inoue A, Inoue R, Tsuno K, Hino A, Shimazu A, Tsutsumi A, Kawakami N. What Kind of Intervention Is Effective for Improving Subjective Well-Being Among Workers? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Psychol. 2020 Nov 13;11:528656. doi: 10.3389/fpsyg.2020.528656. eCollection 2020. PMID: 33281653; PMCID: PMC7691289.
Copy Download .nbib Format: NLM
A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis.

Antibody therapeutics

Beirão BCB, Raposo TP, Imamura LM, Ingberman M, Hupp T, Vojtěšek B, Argyle DJ.
PMID: 33937625
Antib Ther. 2020 Aug 12;3(3):193-204. doi: 10.1093/abt/tbaa018. eCollection 2020 Jul.

CSF-1R is a receptor mostly associated with the mononuclear phagocytic system. However, its expression within tumors has been linked with poor prognosis in both humans and dogs. Accordingly, several reports have demonstrated the beneficial effects of blocking CSF-1R in...

Cite
Beirão BCB, Raposo TP, Imamura LM, et al. A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis. Antib Ther. 2020;3(3):193-204doi: 10.1093/abt/tbaa018.
Beirão, B. C. B., Raposo, T. P., Imamura, L. M., Ingberman, M., Hupp, T., Vojtěšek, B., & Argyle, D. J. (2020). A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis. Antibody therapeutics, 3(3), 193-204. https://doi.org/10.1093/abt/tbaa018
Beirão, Breno C B, et al. "A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis." Antibody therapeutics vol. 3,3 (2020): 193-204. doi: https://doi.org/10.1093/abt/tbaa018
Beirão BCB, Raposo TP, Imamura LM, Ingberman M, Hupp T, Vojtěšek B, Argyle DJ. A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis. Antib Ther. 2020 Aug 12;3(3):193-204. doi: 10.1093/abt/tbaa018. eCollection 2020 Jul. PMID: 33937625; PMCID: PMC7990251.
Copy Download .nbib Format: NLM
Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan.

Journal of diabetes investigation

Nishioka Y, Noda T, Okada S, Myojin T, Kubo S, Higashino T, Nakajima H, Sugiyama T, Ishii H, Imamura T.
PMID: 33660948
J Diabetes Investig. 2021 Oct;12(10):1797-1804. doi: 10.1111/jdi.13540. Epub 2021 Apr 03.

AIM: This study aimed to determine whether there is an association between influenza and new-onset type 1 diabetes.MATERIALS AND METHODS: This population-based retrospective cohort study used data from the National Database of Health Insurance Claims and Specific Health Check-ups...

Cite
Nishioka Y, Noda T, Okada S, et al. Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan. J Diabetes Investig. 2021;12(10):1797-1804doi: 10.1111/jdi.13540.
Nishioka, Y., Noda, T., Okada, S., Myojin, T., Kubo, S., Higashino, T., Nakajima, H., Sugiyama, T., Ishii, H., & Imamura, T. (2021). Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan. Journal of diabetes investigation, 12(10), 1797-1804. https://doi.org/10.1111/jdi.13540
Nishioka, Yuichi, et al. "Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan." Journal of diabetes investigation vol. 12,10 (2021): 1797-1804. doi: https://doi.org/10.1111/jdi.13540
Nishioka Y, Noda T, Okada S, Myojin T, Kubo S, Higashino T, Nakajima H, Sugiyama T, Ishii H, Imamura T. Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan. J Diabetes Investig. 2021 Oct;12(10):1797-1804. doi: 10.1111/jdi.13540. Epub 2021 Apr 03. PMID: 33660948; PMCID: PMC8504904.
Copy Download .nbib Format: NLM
Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia.

Journal of clinical medicine

Imamura T, Oshima A, Narang N, Kinugawa K.
PMID: 34884224
J Clin Med. 2021 Nov 25;10(23). doi: 10.3390/jcm10235523.

BACKGROUND: Sodium zirconium cyclosilicate (SZC), a newly introduced specific potassium binder, is introduced to treat hyperkalemia. However, the implications of SZC in up-titrating renin-angiotensin-aldosterone system inhibitors in patients with systolic heart failure remain unknown.METHODS AND RESULTS: Patients with heart...

Cite
Imamura T, Oshima A, Narang N, et al. Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235523.
Imamura, T., Oshima, A., Narang, N., & Kinugawa, K. (2021). Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235523
Imamura, Teruhiko, et al. "Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235523
Imamura T, Oshima A, Narang N, Kinugawa K. Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia. J Clin Med. 2021 Nov 25;10(23). doi: 10.3390/jcm10235523. PMID: 34884224.
Copy Download .nbib Format: NLM
Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis.

Nephron

Imamura K, Yamamoto S, Suzuki Y, Matsuzawa R, Harada M, Yoshikoshi S, Yoshida A, Matsunaga A.
PMID: 34535597
Nephron. 2021 Sep 14;1-8. doi: 10.1159/000518810. Epub 2021 Sep 14.

INTRODUCTION: There are limited screening tools for sarcopenia in patients undergoing hemodialysis. This study aimed to investigate the reliability and validity of the SARC-F (Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls) questionnaire as a...

Cite
Imamura K, Yamamoto S, Suzuki Y, et al. Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis. Nephron. 2021;1-8doi: 10.1159/000518810.
Imamura, K., Yamamoto, S., Suzuki, Y., Matsuzawa, R., Harada, M., Yoshikoshi, S., Yoshida, A., & Matsunaga, A. (2021). Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis. Nephron, 1-8. https://doi.org/10.1159/000518810
Imamura, Keigo, et al. "Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis." Nephron vol. (2021): 1-8. doi: https://doi.org/10.1159/000518810
Imamura K, Yamamoto S, Suzuki Y, Matsuzawa R, Harada M, Yoshikoshi S, Yoshida A, Matsunaga A. Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis. Nephron. 2021 Sep 14;1-8. doi: 10.1159/000518810. Epub 2021 Sep 14. PMID: 34535597.
Copy Download .nbib Format: NLM
Clinical Implications of Changes in Respiratory Instability Following Transcatheter Aortic Valve Replacement.

Journal of clinical medicine

Ueno Y, Imamura T, Oshima A, Onoda H, Ushijima R, Sobajima M, Fukuda N, Ueno H, Kinugawa K.
PMID: 35012019
J Clin Med. 2022 Jan 05;11(1). doi: 10.3390/jcm11010280.

BACKGROUND: Respiratory instability, which can be quantified using respiratory stability time (RST), is associated with the severity and prognostic impact of the disease in patients with chronic heart failure. However, its clinical implications in patients with severe aortic stenosis...

Cite
Ueno Y, Imamura T, Oshima A, et al. Clinical Implications of Changes in Respiratory Instability Following Transcatheter Aortic Valve Replacement. J Clin Med. 2022;11(1)doi: 10.3390/jcm11010280.
Ueno, Y., Imamura, T., Oshima, A., Onoda, H., Ushijima, R., Sobajima, M., Fukuda, N., Ueno, H., & Kinugawa, K. (2022). Clinical Implications of Changes in Respiratory Instability Following Transcatheter Aortic Valve Replacement. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010280
Ueno, Yohei, et al. "Clinical Implications of Changes in Respiratory Instability Following Transcatheter Aortic Valve Replacement." Journal of clinical medicine vol. 11,1 (2022). doi: https://doi.org/10.3390/jcm11010280
Ueno Y, Imamura T, Oshima A, Onoda H, Ushijima R, Sobajima M, Fukuda N, Ueno H, Kinugawa K. Clinical Implications of Changes in Respiratory Instability Following Transcatheter Aortic Valve Replacement. J Clin Med. 2022 Jan 05;11(1). doi: 10.3390/jcm11010280. PMID: 35012019; PMCID: PMC8745862.
Copy Download .nbib Format: NLM
Factors Associated With Time to Achieve Employment Through Occupational Support Programs in Patients With Mood Disorders: 1 Year Naturalistic Study.

Frontiers in psychiatry

Hayasaka T, Takaesu Y, Nagashima I, Futada M, Nozaki K, Katagiri T, Imamura Y, Kurihara M, Oe Y, Tsuboi T, Watanabe K.
PMID: 33796030
Front Psychiatry. 2021 Mar 16;12:617640. doi: 10.3389/fpsyt.2021.617640. eCollection 2021.

No abstract available.

Cite
Hayasaka T, Takaesu Y, Nagashima I, et al. Factors Associated With Time to Achieve Employment Through Occupational Support Programs in Patients With Mood Disorders: 1 Year Naturalistic Study. Front Psychiatry. 2021;12:617640doi: 10.3389/fpsyt.2021.617640.
Hayasaka, T., Takaesu, Y., Nagashima, I., Futada, M., Nozaki, K., Katagiri, T., Imamura, Y., Kurihara, M., Oe, Y., Tsuboi, T., & Watanabe, K. (2021). Factors Associated With Time to Achieve Employment Through Occupational Support Programs in Patients With Mood Disorders: 1 Year Naturalistic Study. Frontiers in psychiatry, 12617640. https://doi.org/10.3389/fpsyt.2021.617640
Hayasaka, Tomonari, et al. "Factors Associated With Time to Achieve Employment Through Occupational Support Programs in Patients With Mood Disorders: 1 Year Naturalistic Study." Frontiers in psychiatry vol. 12 (2021): 617640. doi: https://doi.org/10.3389/fpsyt.2021.617640
Hayasaka T, Takaesu Y, Nagashima I, Futada M, Nozaki K, Katagiri T, Imamura Y, Kurihara M, Oe Y, Tsuboi T, Watanabe K. Factors Associated With Time to Achieve Employment Through Occupational Support Programs in Patients With Mood Disorders: 1 Year Naturalistic Study. Front Psychiatry. 2021 Mar 16;12:617640. doi: 10.3389/fpsyt.2021.617640. eCollection 2021. PMID: 33796030; PMCID: PMC8007791.
Copy Download .nbib Format: NLM
Showing 1453 to 1459 of 1459 entries